Lilly moves on migraine

By Megan Brodie 3 years ago | In Companies, Products, Regulatory
  • 3 years ago

25 March 2021 Eli Lilly has submitted a pricing application for its migraine therapy EMGALITY…

This is subscriber-only content. Please login to continue reading.